Gainers
-
Summit Therapeutics PLC (ADR) (NASDAQ: SMMT) rose
49.1 percent to $12.90 in pre-market trading. Sarepta Therapeutics and Summit disclosed that they have entered into an
exclusive license and collaboration agreement for European rights to Summit's utrophin modulator pipeline for duchenne muscular
dystrophy drug.
-
Conatus Pharmaceuticals Inc (NASDAQ: CNAT) rose
12.2 percent to $2.20 in the pre-market trading session on Emricasan abstracts.
-
Aralez Pharmaceuticals Inc (NASDAQ: ARLZ) rose
10.7 percent to $5.60 in pre-market trading after the company announced plans to acquire the U.S. rights to Toprol-XL® and its
Authorized Generic from AstraZeneca.
-
Aquinox Pharmaceuticals Inc (NASDAQ: AQXP) rose 7
percent to $15.54 in pre-market trading. Leerink Swann assumed Aquinox Pharmaceuticals with an Outperform rating and a $24.00
price target.
-
Celldex Therapeutics, Inc. (NASDAQ: CLDX) rose
6.8 percent to $4.27 in pre-market trading. Brean Capital assumed Celldex Therapeutics with a Buy rating and a $16.00 price
target.
-
Ollie's Bargain Outlet Holdings Inc (NASDAQ: OLLI) rose 5.9 percent to $27.86 in pre-market trading. Ollie's Bargain Outlet
will replace Parkway Properties Inc (NYSE: PKY) in
the S&P SmallCap 600 after the close on October 5.
-
Darden Restaurants, Inc. (NYSE: DRI) rose 5.2
percent to $64.57 in pre-market trading after the company reported better-than-expected earnings for its first quarter and
raised its earnings outlook for the year.
-
Celyad SA (ADR) (NASDAQ: CYAD) shares rose 5
percent to $23.39 in pre-market trading after dropping 5.58 percent on Monday
-
Pandora Media Inc (NYSE: P) rose 3.6 percent to $14.67
in the pre-market trading. Goldman Sachs added Pandora to its Conviction Buy list and raised the price target from $17.00 to
$19.00.
-
Versartis Inc (NASDAQ: VSAR) rose 2.8 percent to
$12.49 in pre-market trading. Piper Jaffray initiated coverage on Versartis with an Overweight rating.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Harmony Gold Mining Co. (ADR) (NYSE: HMY) shares
fell around 3.7 percent to $3.36 in pre-market trading.
-
Nova Lifestyle Inc (NASDAQ: NVFY) shares fell 3.5
percent to $4.90 in pre-market trading after surging 39.94 percent on Monday.
-
Iradimed Corp (NASDAQ: IRMD) shares fell 3
percent to $16.50 in pre-market trading after the company lowered its Q3 guidance.
-
Sibanye Gold Ltd (ADR) (NYSE: SBGL) shares fell 3.2
percent to $13.50 in pre-market trading after declining 1.34 percent on Monday.
-
GrubHub Inc (NYSE: GRUB) fell 1.3 percent to $42.15
in pre-market trading. Stifel Nicolaus downgraded GrubHub from Buy to Hold.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.